Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission

F. Saraceni, B. Bruno, R. M. Lemoli, G. Meloni, W. Arcese, M. Falda, F. Ciceri, E. P. Alessandrino, G. Specchia, R. Scime, R. Raimondi, A. Bacigalupo, A. Bosi, F. Onida, A. Rambaldi, F. Bonifazi, A. Olivieri

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)163-166
Number of pages4
JournalBone Marrow Transplantation
Issue number1
Publication statusPublished - Jan 1 2017

Cite this